RE:RE:July newsActually did a word search on the last News bit for "July" and found this:
"The Phase II trial team continues to work on preparing, reconciling and closing the patient data base to enable full analysis of the trial results.
This data management work and closeout of clinical sites continues to progress on schedule with third party data analysis expected to occur during the latter part of July.
The Phase II results will be used to design the Phase III program, including greater patient numbers, to more fully evaluate efficacy and safety in hospitalized patients at risk to inflammation in the lungs, kidneys or liver."